Cargando…

Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective

OBJECTIVE: To describe patient characteristics and healthcare costs associated with uveitic macular oedema (UME) in US clinical practices from a commercial payer’s perspective. METHODS AND ANALYSIS: The IBM MarketScan Commercial Subset (1 October 2015–31 March 2020) was used to identify patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hariprasad, Seenu M, Joseph, George, Gagnon-Sanschagrin, Patrick, Serra, Elizabeth, Bhattacharyya, Subrata, Bédard, Jérôme, Guérin, Annie, Albini, Thomas Arno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Uveitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587681/ https://www.ncbi.nlm.nih.gov/pubmed/34786486 http://dx.doi.org/10.1136/bmjophth-2021-000896

Ejemplares similares

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
por: Tang Lee Say, Timothy Lee, et al.
Publicado: (2021)

Comprehensive LncRNA and Potential Molecular Mechanism Analysis in Noninfectious Uveitis
por: Lu, Shiheng, et al.
Publicado: (2023)

Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo
por: Nsiangani Lusambo, Nadine, et al.
Publicado: (2023)

Bibliometric analysis of the uveitis literature and research trends over the past two decades
por: Gao, Tingxiao, et al.
Publicado: (2023)

Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study
por: Granstam, Elisabet, et al.
Publicado: (2023)

Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis
por: Wilson, Leslie, et al.
Publicado: (2023)

Emergent Infectious Uveitis
por: Khairallah, Moncef, et al.
Publicado: (2009)

Managing cataract surgery in patients with uveitis
por: Harapriya, Aravind, et al.
Publicado: (2019)

Evaluation of the Dose-Dependent Inflammatory Response and No-Observable Adverse Effect Level of Intravitreal Endotoxin in the African Green Monkey
por: Corey, Tatiana M., et al.
Publicado: (2022)

Colombian ocular inflammatory diseases epidemiology study (COIDES): prevalence, incidence and sociodemographic characterisation of Scleritis in Colombia, 2015–2020
por: Cifuentes-González, Carlos, et al.
Publicado: (2022)

Tuberculous Uveitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2009)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Viral anterior uveitis
por: Gozzi, Fabrizio, et al.
Publicado: (2022)

Laser flare photometry in uveitis
por: Kesim, Cem, et al.
Publicado: (2022)

Fluorescein and Indocyanine Green Angiography for Uveitis
por: Herbort, Carl P
Publicado: (2009)

Rickettsial disease: An underestimated cause of posterior uveitis
por: Abroug, Nesrine, et al.
Publicado: (2022)

Appraisal, Work-Up and Diagnosis of Anterior Uveitis: A Practical Approach
por: Herbort, Carl P.
Publicado: (2009)

Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay
por: Bouchenaki, Nadia, et al.
Publicado: (2009)

Interpreting posterior uveitis by integrating indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography data: A narrative review
por: Chandrasekaran, Priya R., et al.
Publicado: (2022)

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
por: Schechet, Sidney A, et al.
Publicado: (2019)

Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)
por: Khurana, Rahul N, et al.
Publicado: (2022)

Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis
por: Rothova, Aniki, et al.
Publicado: (2020)

Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
por: Grewal, Dilraj S, et al.
Publicado: (2019)

Inflammatory Choroidal Neovascularization
por: Neri, Piergiorgi, et al.
Publicado: (2009)

Differential Diagnosis of Retinal Vasculitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2009)

An excursion into ocular tuberculosis
por: Yen, Dayna J.S., et al.
Publicado: (2022)

Ipilimumab/nivolumab: Bilateral acute anterior uveitis and cystoid macular oedema: case report
Publicado: (2022)

Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis
por: Schein, Jeff, et al.
Publicado: (2023)

Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
por: Hu, Jason, et al.
Publicado: (2020)

Outcomes of chronic macular hole surgical repair
por: Shukla, Shripaad Y, et al.
Publicado: (2014)

Clinical outcomes of pediatric macular edema associated with non-infectious uveitis
por: Nguyen, Anh Hong, et al.
Publicado: (2021)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Infectious Uveitis
por: Powell, Cynthia C., et al.
Publicado: (2006)

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
por: Matas, Jessica, et al.
Publicado: (2019)

Optical coherence tomography imaging of macular oedema
por: Trichonas, George, et al.
Publicado: (2014)

Remote examination of exudates-impact of macular oedema
por: Punniyamoorthy, Uma, et al.
Publicado: (2018)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration
por: Hariprasad, Seenu M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qv0mfl1qbs6iia08cb1pgkuth8